AYAConnect
Phase NA Completed
63 enrolled
FIDURA
Phase 3 Completed
354 enrolled
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
Completed
300 enrolled
HERO
Phase NA Completed
113 enrolled
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
PRECANU
Completed
40 enrolled
SPIRIT
Phase 2 Completed
121 enrolled 12 charts
RADIANT
Completed
16 enrolled
MIFADORESOL
Completed
100 enrolled
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Phase 1 Completed
117 enrolled
ASPIRE
Phase NA Completed
340 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Completed
2,310 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
Phase 2 Completed
130 enrolled 12 charts
ONCODAGE
Phase NA Completed
1,674 enrolled 9 charts
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
Phase 2 Completed
304 enrolled 12 charts
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy
Phase NA Completed
78 enrolled
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
Phase NA Completed
340 enrolled
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
Phase NA Completed
200 enrolled
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Phase 1/2 Completed
25 enrolled 14 charts
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
Phase 2 Completed
36 enrolled 5 charts
EPAC
Phase NA Completed
213 enrolled 20 charts
Partnership for Healthy Seniors
Phase NA Completed
2,593 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
CPTD
Phase 3 Completed
200 enrolled
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
38 enrolled
Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight
Phase 2 Completed
641 enrolled
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer
Phase NA Completed
177 enrolled
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
Phase 3 Completed
141 enrolled
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase 1 Completed
51 enrolled
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Phase 2 Completed
51 enrolled 6 charts
Spectroscopy With Surface Coils and Decoupling
Phase 1 Completed
582 enrolled
PallRad1
Completed
98 enrolled
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
Completed
80 enrolled
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Phase 1 Completed
33 enrolled
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
20 enrolled
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients
Phase NA Completed
329 enrolled
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
14 enrolled
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
Phase 1/2 Completed
66 enrolled
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Phase 1 Completed
41 enrolled
Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis
Phase NA Completed
250 enrolled
Chemotherapy in Treating Patients With Solid Tumors
Phase 1/2 Completed
57 enrolled
Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer
Phase 1/2 Completed
60 enrolled
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
Completed
64 enrolled
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Phase 2 Completed
180 enrolled